Skip to main content
Premium Trial:

Request an Annual Quote

From BigCo to TinyCo: How to Succeed at a Pint-Sized Company

Over at In the Pipeline, Derek Lowe has a post about a career issue: what happens when someone from a large biotech or pharma suddenly winds up at a very small company? Lowe says that hurdles include no longer having direct reports (that can be a challenge when it comes to looking for another job) and not having access to the kind of fancy equipment and technology platforms that are commonplace at very large companies. Still, Lowe believes heading to a small company can be a good move: "All in all, you’ve most likely got a better chance of having your fingerprints on a clinical candidate than you did back at BigCo, so make the most of it," he writes.

 

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.